Zobrazeno 1 - 10 of 237 pro vyhledávání: '"Mølck C"'
1
Akademický článek
Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex.
Autor: Tollenaere MAX; LEO Pharma A/S, Ballerup, Denmark., Mølck C; LEO Pharma A/S, Ballerup, Denmark., Henderson I; Sygnature Discovery, Nottingham, United Kingdom., Pollack S; Sygnature Discovery, Nottingham, United Kingdom., Addis P; Sygnature Discovery, Nottingham, United Kingdom., Petersen HH; LEO Pharma A/S, Ballerup, Denmark., Norsgaard H; LEO Pharma A/S, Ballerup, Denmark.
Publikováno v: JID innovations : skin science from molecules to population health [JID Innov] 2023 Jul 04; Vol. 3 (5), pp. 100214. Date of Electronic Publication: 2023 Jul 04 (Print Publication: 2023).
Zobrazit plný text záznamu
2
Akademický článek
572 Tralokinumab does not affect endogenous IL13Ra2-mediated regulation of free IL-13
Autor: Tollenaere, M.A., Mølck, C., Heibroch Petersen, H., Norsgaard, H.
Publikováno v: In Journal of Investigative Dermatology August 2022 142(8) Supplement:S98-S98
Zobrazit plný text záznamu
3
Akademický článek
Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models.
Autor: Shembrey C; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia., Smith J; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia., Grandin M; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia., Williams N; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia., Cho HJ; Biological Optical Microscopy Platform, University of Melbourne, Melbourne, VIC 3010, Australia., Mølck C; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia., Behrenbruch C; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3010, Australia.; Department of General Surgical Specialties, The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3050, Australia., Thomson BN; Department of General Surgical Specialties, The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3050, Australia.; Department of Surgery, the Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3050, Australia., Heriot AG; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3010, Australia.; Department of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Department of Surgery, St Vincent's Hospital, Melbourne, VIC 3065, Australia., Merino D; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia.; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.; Department of Medical Biology, The Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, VIC 3010, Australia., Hollande F; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia.
Publikováno v: Cancers [Cancers (Basel)] 2022 Jan 24; Vol. 14 (3). Date of Electronic Publication: 2022 Jan 24.
Zobrazit plný text záznamu
4
Akademický článek
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Autor: Giuffrida L; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Henderson MA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Meyran D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Todd KL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Mardiana S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Mølck C; Department of Pathology, University of Melbourne, Parkville, Vic, Australia., Stewart GD; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia., Solomon BJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Parish IA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia., Harrison SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia.; Clinical Haematology and Centre of Excellence for Cellular Immunotherapies, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Vic, Australia., Kats LM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia.; Department of Pathology, University of Melbourne, Parkville, Vic, Australia., House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. imran.house@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia. imran.house@petermac.org., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. phil.darcy@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia. phil.darcy@petermac.org.; Department of Pathology, University of Melbourne, Parkville, Vic, Australia. phil.darcy@petermac.org.; Department of Immunology, Monash University, Clayton, Vic, Australia. phil.darcy@petermac.org., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. paul.beavis@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vic, Australia. paul.beavis@petermac.org.
Publikováno v: Nature communications [Nat Commun] 2021 May 28; Vol. 12 (1), pp. 3236. Date of Electronic Publication: 2021 May 28.
Zobrazit plný text záznamu
5
Akademický článek
Fragment-Based Discovery of Pyrazolopyridones as JAK1 Inhibitors with Excellent Subtype Selectivity.
Autor: Hansen BB, Jepsen TH, Larsen M, Sindet R, Vifian T, Burhardt MN, Larsen J, Seitzberg JG, Carnerup MA, Jerre A, Mølck C, Lovato P, Rai S; Medicinal Chemistry, GVK Biosciences Private Limited, 28 A, IDA Nacharam, Hyderabad 500076, India., Nasipireddy VR; Medicinal Chemistry, GVK Biosciences Private Limited, 28 A, IDA Nacharam, Hyderabad 500076, India., Ritzén A
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2020 Jul 09; Vol. 63 (13), pp. 7008-7032. Date of Electronic Publication: 2020 Jun 08.
Zobrazit plný text záznamu
6
Akademický článek
PET imaging of colon cancer CD73 expression using cysteine site-specific 89Zr-labeled anti-CD73 antibody.
Autor: Jung, Kyung-Ho1,2 (AUTHOR), Kim, Mina1,2 (AUTHOR), Jung, Hye Jin1,2 (AUTHOR), Koo, Hyun Jung1,2 (AUTHOR), Kim, Jung-Lim1,2 (AUTHOR), Lee, Hyunjong1 (AUTHOR), Lee, Kyung-Han1,2 (AUTHOR) khleenm@naver.com
Publikováno v: Scientific Reports. 8/4/2024, Vol. 14 Issue 1, p1-12. 12p.
Zobrazit plný text záznamu
7
Akademický článek
Current Understanding of the Role of Adenosine Receptors in Cancer.
Autor: Venugopala, Katharigatta Narayanaswamy1,2 (AUTHOR) kvenugopala@kfu.edu.sa, Buccioni, Michela3 (AUTHOR) michela.buccioni@unicam.it
Publikováno v: Molecules. Aug2024, Vol. 29 Issue 15, p3501. 31p.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy.
Autor: Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3000, Australia. Kevin.Sek@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, 3010 Parkville, Australia. Kevin.Sek@petermac.org., Mølck C; Department of Pathology, University of Melbourne, Parkville 3010, Australia. christina.moelck@gmail.com., Stewart GD; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Australia. gregory.stewart@monash.edu., Kats L; Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3000, Australia. lev.kats@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, 3010 Parkville, Australia. lev.kats@petermac.org., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3000, Australia. phil.darcy@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, 3010 Parkville, Australia. phil.darcy@petermac.org.; Department of Pathology, University of Melbourne, Parkville 3010, Australia. phil.darcy@petermac.org.; Department of Immunology, Monash University, Clayton 3052, Australia. phil.darcy@petermac.org., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3000, Australia. Paul.Beavis@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, 3010 Parkville, Australia. Paul.Beavis@petermac.org.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2018 Dec 02; Vol. 19 (12). Date of Electronic Publication: 2018 Dec 02.
Zobrazit plný text záznamu
10
Akademický článek
A Spatio-Temporal Model and Inference Tools for Longitudinal Count Data on Multicolor Cell Growth.
Autor: Qiao P; The University of Melbourne, Melbourne, Australia., Mølck C; The University of Melbourne, Melbourne, Australia., Ferrari D; Free University of Bozen-Bolzano, Bolzano, Italy., Hollande F; The University of Melbourne, Melbourne, Australia.
Publikováno v: The international journal of biostatistics [Int J Biostat] 2018 Jul 07; Vol. 14 (2). Date of Electronic Publication: 2018 Jul 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje